Evidence map›Paper›PMID 35529298›Full record

ArticleCase reports in oncology

Poor Outcome due to the Plasmacytoid Variant of Urothelial Carcinoma.

Kyotaro Fukuta, Keito Shiozaki, Saki Kobayashi, Ryoichi Nakanishi, Hirofumi Izaki, Kazuya Kanda, Tohru Inai, Eiji Kudo, Tomoya Fukawa, Kunihisa Yamaguchi and 3 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kyotaro FukutaDepartment of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Keito ShiozakiDepartment of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Saki KobayashiDepartment of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Ryoichi NakanishiDepartment of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Hirofumi IzakiDepartment of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Kazuya KandaDepartment of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Tohru InaiDepartment of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Eiji KudoDepartment of Pathology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Tomoya FukawaDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Kunihisa YamaguchiDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Yasuyo YamamotoDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Masayuki TakahashiDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Hiro-Omi KanayamaDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Tokushima Prefectural Central Hospital · JPTokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 72-year-old man visited our hospital due to pollakiuria and lower abdominal pain. Urinary cytology was positive, and cystoscopy revealed diffuse edematous nonpapillary tumor. We performed transurethral biopsy, and clinical stage T3 plasmacytoid variant of urothelial carcinoma (PUC) was diagnosed. Although we planned for radical cystectomy, peritoneal dissemination and lung and pelvic lymph node metastases appeared 3 weeks after the initial visit. We also planned for chemotherapy; however, the metastases rapidly progressed, and he died 7 weeks after the biopsy. PUC is rare and shows an aggressive clinical course and poor prognosis.

Indexed as

Bladder cancerPlasmacytoid variant of urothelial carcinomaUrothelial carcinomaVariant histology

Identifiers

PMID35529298
PMCPMC9035940
OpenAlexW4221029873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.